PARLIAMENTARY WRITTEN QUESTION
Medicines and Healthcare products Regulatory Agency: Redundancy (15 October 2021)
Question Asked
To ask the Secretary of State for Health and Social Care, what discussions he has had on potential redundancies with executive officers at the Medicines and Healthcare Products Regulatory Agency.
Asked by:
Feryal Clark (Labour)
Asked by:
Feryal Clark (Labour)
Answer
The Department regularly meets with officials at the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss a range of issues, including its transformation plans.
The Department has not made a specific assessment of the potential effect of redundancies at the MHRA. The MHRA continues to involve trades unions and employees through formal consultation as well as continuing opportunities for engagement with senior leaders.
Answered by:
Edward Argar (Conservative)
21 October 2021
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.